Home › Stocks › FATE › All Fund Holders
FATE — FATE THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 48 · Reported value held: $326.86M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Lone Pine Capital history | Q3 2021 | 2.20M | $130.35M | 0.44% | New |
| Capital World Investors history | Q4 2022 | 5.59M | $56.42M | 0.01% | Reduce |
| ARK Invest history | Q4 2022 | 4.21M | $42.53M | 0.38% | Reduce |
| BlackRock Inc history | Q2 2026 | 7.30M | $19.71M | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 3.84M | $10.36M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 3.59M | $9.69M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 8.97M | $8.82M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 2.98M | $8.05M | 0.01% | Hold |
| Casdin Capital history | Q4 2023 | 2.05M | $7.67M | 0.75% | Hold |
| Millennium Management history | Q2 2026 | 2.43M | $6.57M | 0.00% | New |
| Goldman Sachs Group history | Q2 2026 | 2.05M | $5.53M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 1.32M | $3.57M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 1.09M | $2.95M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 694.58K | $1.88M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 610.95K | $1.65M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 590.18K | $1.59M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 492.43K | $1.33M | 0.00% | New |
| Farallon Capital Management history | Q1 2022 | 31.90K | $1.24M | 0.01% | Reduce |
| Point72 Asset Management history | Q2 2026 | 442.23K | $1.19M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 265.98K | $718.15K | 0.00% | Reduce |
| Moore Capital Management history | Q3 2022 | 29.99K | $672.00K | 0.02% | New |
| Wellington Management Group history | Q2 2026 | 245.81K | $663.70K | 0.00% | New |
| Northern Trust Corp history | Q2 2026 | 242.67K | $655.21K | 0.00% | Reduce |
| MFS Investment Management history | Q3 2024 | 163.10K | $570.86K | 0.00% | Reduce |
| CPP Investments history | Q2 2024 | 132.70K | $435.26K | 0.00% | Hold |
| Bank of America Corp history | Q2 2026 | 153.71K | $415.01K | 0.00% | Reduce |
| D. E. Shaw & Co history | Q1 2025 | 433.19K | $342.26K | 0.00% | Reduce |
| Royce & Associates history | Q1 2024 | 43.40K | $318.55K | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 63.65K | $171.84K | 0.00% | Reduce |
| Norges Bank Investment Management history | Q4 2023 | 42.67K | $159.59K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 49.08K | $132.50K | 0.00% | Add |
| Arrowstreet Capital history | Q2 2026 | 30.18K | $81.47K | 0.00% | New |
| Janus Henderson Group history | Q3 2023 | 33.96K | $72.17K | 0.00% | Hold |
| Citigroup Inc history | Q2 2026 | 19.63K | $53.00K | 0.00% | Add |
| Principal Global Investors history | Q2 2024 | 13.67K | $44.83K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 15.16K | $40.93K | 0.00% | Reduce |
| Manulife Financial history | Q1 2026 | 32.12K | $38.54K | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 13.41K | $36.22K | 0.00% | New |
| Prudential Financial history | Q1 2026 | 26.33K | $31.60K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 11.38K | $30.73K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 9.00K | $21.77K | 0.00% | New |
| Amundi US history | Q3 2024 | 4.99K | $15.32K | 0.00% | Hold |
| Legal & General Investment Management America history | Q1 2026 | 10.40K | $12.48K | 0.00% | Hold |
| Franklin Resources history | Q2 2025 | 10.20K | $11.42K | 0.00% | Hold |
| PNC Financial Services history | Q2 2026 | 1.05K | $2.84K | 0.00% | Reduce |
| Baillie Gifford & Co history | Q1 2023 | 372 | $2.12K | 0.00% | Hold |
| Lazard Asset Management history | Q4 2022 | 89.40K | $901 | 0.00% | Reduce |
| T. Rowe Price Associates history | Q1 2026 | 76.63K | $92 | 0.00% | Add |